CompaniesByCap
ESPR
Esperion Therapeutics Inc. (ESPR)
NASDAQ · Healthcare

Esperion Therapeutics Inc. Cash Flow 2018–2025

Income StatementBalance SheetCash Flow
Dec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016Dec 2015
Operating Activities
Operating Cash Flow-13.1M-23.7M-135.5M-174.8M-263.8M-85.2M-70.3M-148.6M-131.3M-47.7M-38.2M
Depreciation & Amort.
Investing Activities
Capital Expenditure0317,000000869,000953,000151,00019,00094,000325,000
Free Cash Flow-13.1M-24.0M-135.5M-174.8M-263.8M-86.0M-71.3M-148.8M-131.3M-47.8M-38.5M
Financing Activities
Dividends Paid
Stock Buybacks055.0M00

Esperion Therapeutics Inc. Cash Flow — FAQ

Esperion Therapeutics Inc. (ESPR) cash flow over the last 8 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see ESPR's cash flow history?

The chart and table above show Esperion Therapeutics Inc.'s cash flow by year and by quarter, including the growth rate.